How to buy Dexcom stock?
DexCom Inc. (DXCM) is priced at $455.78 after the most recent trading session. At the very opening of the session, the stock price was $489.16 and reached a high price of $489.16, prior to closing the session it reached the value of $490.38. The stock ...
What is the stock price of Dexcom?
DexCom, Inc. is headquartered in San Diego, California. Full-Time Employees: 5,500. Market Cap 44.811B USD. DexCom total assets for the quarter ending September 30, 2021 were $4.776B, Stock price 462.34-9.15 (-1.94%) At close: 04:00 PM EST DexCom Inc (DXCM.xnas)Analysis. DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring ("CGM"), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2021, will be approximately ...
How much does Dexcom pay?
The average Dexcom salary ranges from approximately $33,600 per year for Senior Material Handler to $150,982 per year for Product Owner. Average Dexcom hourly pay ranges from approximately $14.00 per hour for Technical Support Representative to $37.47 per hour for Facilities Engineer II.
Is Dexcom stock a buy?
DexCom, Inc. (NASDAQ:DXCM) has been assigned an average recommendation of “Buy” from the seventeen research firms that are covering the company, Marketbeat Ratings reports. One investment ...
See more
Is DexCom a publicly traded company?
(NASDAQ:DXCM - News) today announced the initial public offering of 4,700,000 shares of common stock at a price of $12.00 per share. DexCom is selling all of the shares in the offering.
Is DexCom stock overpriced?
Valuation metrics show that DexCom, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of DXCM, demonstrate its potential to underperform the market.
Can I buy DexCom stock?
Buy DexCom shares from these brokerages Compare special offers, low fees and a wide range of types of investments among top trading platforms. Trade stocks in the app or online with $0 commissions.
Does DexCom stock pay dividends?
DXCM DexCom, Inc. DXCM does not currently pay a dividend.
Is dexcom a good buy?
DexCom has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 13 buy ratings, 1 hold rating, and no sell ratings.
Is dexcom still a buy?
DexCom is a solid buy for long-term investors Whether it grows internationally or domestically, there will be no shortage of opportunities for DexCom to generate significant growth for just not years but potentially decades.
Who owns DexCom stock?
Top 10 Owners of Dexcom IncStockholderStakeShares ownedThe Vanguard Group, Inc.10.35%40,637,448BlackRock Fund Advisors5.70%22,359,524Baillie Gifford & Co.4.64%18,217,172Sands Capital Management LLC4.27%16,756,9806 more rows
Will DexCom stock go up?
Stock Price Forecast The 17 analysts offering 12-month price forecasts for Dexcom Inc have a median target of 120.00, with a high estimate of 150.00 and a low estimate of 87.00. The median estimate represents a +48.83% increase from the last price of 80.63.
Who owns DexCom?
In a recent interview, Dexcom CEO Kevin Sayer shared his hopes for the technology and how the device-maker is handling a growing number of competitors. Responses have been edited for length and clarity. In light of your recent study results, are you seeing more interest in using CGMs for type 2 diabetes?
Should I buy or sell DexCom stock right now?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DexCom in the last twelve months. There are currently 1 hold rating and 1...
What is DexCom's stock price forecast for 2022?
14 equities research analysts have issued twelve-month price objectives for DexCom's stock. Their DXCM stock forecasts range from $90.75 to $163.75...
How has DexCom's stock price performed in 2022?
DexCom's stock was trading at $134.2375 at the start of the year. Since then, DXCM shares have increased by 118.9% and is now trading at $293.85....
When is DexCom's next earnings date?
DexCom is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for DexCom .
How were DexCom's earnings last quarter?
DexCom, Inc. (NASDAQ:DXCM) released its earnings results on Thursday, April, 28th. The medical device company reported $0.08 EPS for the quarter, m...
When did DexCom's stock split? How did DexCom's stock split work?
DexCom's stock split on the morning of Friday, June 10th 2022. The 4-1 split was announced on Friday, March 25th 2022. The newly created shares wer...
What guidance has DexCom issued on next quarter's earnings?
DexCom updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue g...
Who are DexCom's key executives?
DexCom's management team includes the following people: Mr. Kevin Ronald Sayer , Exec. Chairman, CEO & Pres (Age 64, Pay $2.39M) Mr. Jereme M. S...
What is Kevin Sayer's approval rating as DexCom's CEO?
347 employees have rated DexCom CEO Kevin Sayer on Glassdoor.com . Kevin Sayer has an approval rating of 88% among DexCom's employees.
About DexCom
DexCom (NASDAQ:DXCM) Frequently Asked Questions
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F.
Nasdaq Global Select
15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DexCom in the last twelve months. There are currently 1 hold rating and 14 buy ratings for the stock.
Environmental, Social, and Governance Rating
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
